Int. J. Environ. Res. Public Health 2009, 6 219 16. Brody, J.S.; Spira, A. Chronic Obstructive Pulmonary Disease, Inflammation, and Lung Cancer. Proc. Am. Thorac. Soc. 2006, 3, 535-538. 17. Saetta, M. Airway Inflammation in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 1999, 160, S17-S20. 18. Saetta, M.; Di Stefano, A.; Maestrelli, P.; Ferraresso, A.; Drigo, R.; Potena, A.; Ciaccia, A.; Fabbri, L.M. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am. Rev. Respir. Dis. 1993, 147, 301-306. 19. Rutgers, S.R.; Postma, D.S. ten Hacken, N.H.; Kauffman, H.; van der Mark, T.W.; Koeter, G.; Timens, W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 2000, 55, 12-18. 20. Willemse, B.W.M.; ten Hacken, N.H.T.; Rutgers, B.; Lesman-Leegte, I.G.A.T.; Postma, D.S.; Timens, W. Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers. Eur. Respir. J. 2005, 26, 835-845. 21. Soriano, J.B.; Agust, A. The yin and yang of COPD: or balancing repair (yang) and inflammation (yin) Eur. Respir. J. 2008, 32, 1426-1427. 22. Agusti, A.; Macnee, W.; Donaldson, K.; Cosio, M. Hypothesis: does COPD have an autoimmune component? Thorax 2003, 58, 832-834. 23. Cosio, M.G. Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease. Eur. Respir. J. 2004, 24, 3-5. 24. Taylor, D.H. Jr; Hasselblad, V.; Henley, S.J.; Thun, M.J.; Sloan, F.A. Benefits of smoking cessation for longevity. Am. J. Public Health 2002, 92, 990-996. 25. van Schayck, C.P.; Kaper, J. Smoking and COPD: will they ever vanish into smoke? (Editorial). Primary Care Respir. J. 2006, 15, 81-83. 26. Xu, X.; Dockery, D.W.; Ware, J.H.; Speizer, F.E.; Ferris, B.G. Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment. Am. Rev. Respir. Dis. 1992, 146, 1345-1348. 27. Di Stefano, A.; Capelli, A.; Lusuardi, M.; Balbo, P.; Vecchio, C.; Maestrelli, P.; Mapp, C.E.; Fabbri, L.M.; Donner, C.F.; Saetta, M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am. J. Respir. Crit. Care Med. 1998, 158, 1277-1285. 28. Anthonisen, N.R.; Connett, J.E.; Kiley, J.P.; Altose, M.D.; Bailey, W.C.; Buist, A.S.; Conway, W.A. Jr.; Enright, P.L., Kanner, R.E.; O'Hara, ‘et al’. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV 1. The Lung Health Study. JAMA 1994, 272, 1497-1505. 29. Anthonisen, N.R.; Skeans, M.A.; Wise, R.A.; Manfreda, J.; Kanner, R.E.; Connett, J.E. The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality.A Randomized Clinical Trial. Ann. Intern. Med. 2005, 142, 233-239. 30. Murray, R.P.; Anthonissen, N.R.; Connett, J.E.; Wise, R.A.; Lindgren, P.G.; Greene, P.G.; Nides, M.A. Effect of multiple attempts to quit smoking and relapses to smoking on pulmonary function. J. Clin. Epid. 1998, 51, 1317-1326. 31. Kanner, R.E.; Connett, J.E.; Williams, D.E.; Buist, A.S. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in